Clinical Trials Logo

Filter by:
NCT ID: NCT00343447 Withdrawn - Leukemia Clinical Trials

Cyclophosphamide and Rituximab Followed By Vaccine Therapy in Treating Patients With Chronic Lymphocytic Leukemia

Start date: August 2006
Phase: Phase 2
Study type: Interventional

RATIONALE: Drugs used in chemotherapy, such as cyclophosphamide, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. Vaccines may help the body build an effective immune response to kill cancer cells. Giving cyclophosphamide and rituximab together with vaccine therapy may kill more cancer cells. PURPOSE: This randomized phase II trial is studying cyclophosphamide and rituximab followed by two different schedules of vaccine therapy to compare how well they work in treating patients with chronic lymphocytic leukemia.

NCT ID: NCT00340223 Withdrawn - AIDS Clinical Trials

HLA-B35 Alleles and AIDS

Start date: September 2005
Phase: N/A
Study type: Observational

This study will identify variations in the genome of the human immunodeficiency virus (HIV) early after infection and following the development of AIDS. It will analyze genetic material and clinical data from HIV-positive individuals to assess differences in viral epitopes between patients with two different gene alleles (alternative forms of a gene)-B*3501 and B*3503. (An epitope is a molecular region on the surface of an antigen capable of eliciting an immune response and of combining with the specific antibody produced by such a response.) HIV disease in people with the B*3503 allele progresses significantly faster than it does in people with the B*3501 allele. This study might provide information that is potentially useful in developing a successful HIV vaccine. Blood samples and clinical data for analysis will be obtained from the Johns Hopkins Bloomberg School of Public Health; the University of Pittsburgh; the John H. Stroger, Jr. Hospital of Cook County; the Howard Brown Health Center; Northwestern University; and the University of California at Los Angeles.

NCT ID: NCT00338546 Withdrawn - Clinical trials for Cocaine Induced Sympathoexciation and Vasoconstriction

Study to Improve Scientific Understanding of the Cardiovascular Actions of Cocaine

Start date: n/a
Phase: Phase 1
Study type: Interventional

The purpose of this study is to improve the scientific understanding of the cardiovascular actions of cocaine, in particular the ability of cocaine to increase blood pressure.

NCT ID: NCT00338273 Withdrawn - Bipolar Disorder Clinical Trials

A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode

Start date: December 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate flexible doses (5-30 mg) of aripiprazole in patients with bipolar depression.

NCT ID: NCT00335855 Withdrawn - Influenza Clinical Trials

Pharma-Pen (Formerly Innoject) Auto-injectory TIV

Start date: n/a
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained users to self-administer Influenza vaccines as compared to standard IM injections administered by a licensed healthcare professional (e.g. a nurse). Participants will be 120 healthy men and women aged 18 - 50 years who have not received influenza vaccine for at least four years and who have no experience in giving intramuscular or subcutaneous injections. Subjects will be randomly placed in one of three treatment types. They will receive one injection of commercially available Influenza vaccine and will be evaluated over the course of six months.

NCT ID: NCT00335101 Withdrawn - Diabetes Mellitus Clinical Trials

Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography

Start date: June 2006
Phase: Phase 4
Study type: Interventional

The study is to evaluate and compare the effects on kidney function of three iodinated contrast media (CM) in patients at risk of kidney damage evaluating serum creatinine (Scr) concentrations up to three days after CM administration.

NCT ID: NCT00334100 Withdrawn - Multiple Sclerosis Clinical Trials

Treadmill Training in Chronic MS: Efficacy and Cost-effectiveness

Start date: April 2006
Phase: N/A
Study type: Interventional

The purpose of the study is to determine whether treadmill training is safe and beneficial in patients with walking difficulty because of multiple sclerosis.

NCT ID: NCT00333632 Withdrawn - Sleep Clinical Trials

Effect of Dexmedetomidine Upon Sleep Postoperatively

Start date: June 2006
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether an intravenous infusion of dexmedetomidine administered to surgical patients intra-operatively will improve the characteristics of sleep post-operatively.

NCT ID: NCT00331019 Withdrawn - Clinical trials for Group B Streptococcus Neonatal Sepsis

Rapid Detection of Group B Strep- 35-37 Week Study

Start date: July 2006
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether a rapid bedside diagnosis of Group B Strep growing in the vagina and rectum can be performed with similar success to the routine culture.

NCT ID: NCT00330642 Withdrawn - Clinical trials for Streptococcal Infections

Rapid Detection of Group B Streptococcus (Strep)-Labor and Delivery Study

Start date: July 2006
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether a rapid bedside diagnosis of group B strep (GBS) growing in the vagina and rectum can be performed with similar success to the routine culture in women who are in labor.